Leber Hereditary Optic Neuropathy Clinical Trials
2 recruiting trials for Leber Hereditary Optic Neuropathy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Leber Hereditary Optic Neuropathy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Randy Kardon (1), MD Stem Cells (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is LSFG-NAVI (device, 1 trial), followed by Arm 1.
Track Leber Hereditary Optic Neuropathy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
New Non-invasive Modalities for Assessing Retinal Structure and Function
This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of...
Stem Cell Ophthalmology Treatment Study II
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Leber Hereditary Optic Neuropathy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Leber Hereditary Optic Neuropathy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Leber Hereditary Optic Neuropathy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.